TickerFacts.

GT Biopharma, Inc. (GTBP) — Operating Income

Annual figures by period end, from SEC filings.

2010-12-31: -$2.50M2011-12-31: -$3.93M2012-12-31: -$3.51M2013-12-31: -$793.0K2014-12-31: -$2.40M2015-12-31: -$8.93M2016-12-31: -$9.37M2017-12-31: -$135.57M2018-12-31: -$250.07M2019-12-31: $16.06M2020-12-31: -$6.76M2021-12-31: -$57.52M2022-12-31: -$21.26M2023-12-31: -$13.58M2024-12-31: -$14.36M2025-12-31: -$12.42M-$12.42M
2010-12-31Operating Income (USD)2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$12.42M—2026-03-02From 2025-01-01
2024-12-31-$14.36M—2026-03-02From 2024-01-01
2023-12-31-$13.58M—2025-02-21From 2023-01-01
2022-12-31-$21.26M—2024-03-26From 2022-01-01
2021-12-31-$57.52M—2023-03-30From 2021-01-01
2020-12-31-$6.76M-142.1%2022-03-28From 2020-01-01
2019-12-31$16.06M—2021-04-16From 2019-01-01
2018-12-31-$250.07M—2020-03-27From 2018-01-01
2017-12-31-$135.57M—2019-03-29From 2017-01-01
2016-12-31-$9.37M—2018-03-01From 2016-01-01
2015-12-31-$8.93M—2018-02-28From 2015-01-01
2014-12-31-$2.40M—2018-02-28From 2014-01-01
2013-12-31-$793.0K—2015-03-31From 2013-01-01
2012-12-31-$3.51M—2015-01-08From 2012-01-01
2011-12-31-$3.93M—2014-11-18From 2011-01-01
2010-12-31-$2.50M—2012-04-16From 2010-01-01